[HTML][HTML] CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes andphenytoin adverse reactions correlation
CA Twardowschy, LC Werneck, RH Scola… - Arquivos de neuro …, 2011 - SciELO Brasil
OBJECTIVE: CYP2C9 is a major enzyme in human drug metabolism and the polymorphism
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
[PDF][PDF] CYP2C9 polymorphism in patients with epilepsy
CA Twardowschy, LC Werneck, RH Scola… - Arq …, 2011 - academia.edu
Objective: CYP2C9 is a major enzyme in human drug metabolism and the polymorphism
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes andphenytoin adverse reactions correlation
CA Twardowschy, LC Werneck, RH Scola, LD Paola… - sidalc.net
OBJECTIVE: CYP2C9 is a major enzyme in human drug metabolism and the polymorphism
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
[PDF][PDF] CYP2C9 polymorphism in patients with epilepsy
CA Twardowschy, LC Werneck, RH Scola… - Arq …, 2011 - researchgate.net
Objective: CYP2C9 is a major enzyme in human drug metabolism and the polymorphism
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
[PDF][PDF] CYP2C9 polymorphism in patients with epilepsy
CA Twardowschy, LC Werneck… - Arq …, 2011 - pdfs.semanticscholar.org
Objective: CYP2C9 is a major enzyme in human drug metabolism and the polymorphism
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes andphenytoin adverse reactions correlation
CA Twardowschy, LC Werneck, RH Scola… - Arquivos de Neuro …, 2011 - SciELO Brasil
OBJECTIVE: CYP2C9 is a major enzyme in human drug metabolism and the polymorphism
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
[HTML][HTML] CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes andphenytoin adverse reactions correlation
CA Twardowschy, LC Werneck, RH Scola… - Arq …, 2011 - pesquisa.bvsalud.org
OBJECTIVE: CYP2C9 is a major enzyme in human drug metabolism and the polymorphism
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes and phenytoin adverse reactions correlation
CA Twardowschy, LC Werneck… - Arquivos de neuro …, 2011 - pubmed.ncbi.nlm.nih.gov
Objective CYP2C9 is a major enzyme in human drug metabolism and the polymorphism
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes and phenytoin adverse reactions correlation.
CA Twardowschy, LC Werneck, RH Scola… - Arquivos de Neuro …, 2011 - europepmc.org
Objective CYP2C9 is a major enzyme in human drug metabolism and the polymorphism
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
[PDF][PDF] CYP2C9 polymorphism in patients with epilepsy
CA Twardowschy, LC Werneck, RH Scola… - Arq …, 2011 - scholar.archive.org
Objective: CYP2C9 is a major enzyme in human drug metabolism and the polymorphism
observed in the corresponding gene may affect therapeutic outcome during treatment. The …
observed in the corresponding gene may affect therapeutic outcome during treatment. The …